Adding Epigenetic Drug to Standard Chemotherapy Was Effective in Pilot Study for T-cell Lymphoma | Newsroom

Red and white blood cell illustration. Credit: Shutterstock. Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin...